Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,808 | 324 | 98.9% |
| Education | $65.99 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $785.55 | 58 | $0 (2024) |
| Lilly USA, LLC | $675.92 | 38 | $0 (2024) |
| ABBVIE INC. | $573.38 | 37 | $0 (2024) |
| Amgen Inc. | $324.63 | 19 | $0 (2024) |
| GlaxoSmithKline, LLC. | $320.39 | 17 | $0 (2024) |
| PFIZER INC. | $304.57 | 16 | $0 (2024) |
| Astellas Pharma US Inc | $282.85 | 8 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $249.73 | 12 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $245.95 | 10 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $236.08 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,061 | 105 | Novo Nordisk Inc ($245.46) |
| 2023 | $2,035 | 103 | Lilly USA, LLC ($348.41) |
| 2022 | $1,492 | 97 | Novo Nordisk Inc ($356.26) |
| 2021 | $285.68 | 20 | Novo Nordisk Inc ($48.48) |
All Payment Transactions
325 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $22.94 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 11/26/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $31.38 | General |
| Category: Transcatheter Heart Valves | ||||||
| 11/19/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: Analgesic | ||||||
| 11/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Biological | ||||||
| 11/06/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: Analgesic | ||||||
| 11/04/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Neuroscience | ||||||
| 11/04/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Insomnia | ||||||
| 10/30/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $5.46 | General |
| Category: Cardiology | ||||||
| 10/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Obesity | ||||||
| 10/28/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $3.52 | General |
| 10/24/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $18.76 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 10/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: DIABETES | ||||||
| 10/12/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | PROTEGA PHARMACEUTIALS INC | ROXYBOND (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Pain Management | ||||||
| 10/07/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: PAIN | ||||||
| 10/01/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Oncology | ||||||
| 09/30/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Neuroscience | ||||||
| 09/24/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: ADHD | ||||||
| 09/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: RESPIRATORY | ||||||
| 09/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.03 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $128.15 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 694 | 892 | $135,909 | $48,590 |
| 2022 | 10 | 586 | 799 | $130,135 | $38,096 |
| 2021 | 10 | 516 | 615 | $88,541 | $30,872 |
| 2020 | 11 | 524 | 616 | $75,820 | $25,017 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 355 | 469 | $87,234 | $22,682 | 26.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 188 | 188 | $30,456 | $20,609 | 67.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $3,640 | $1,826 | 50.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $6,976 | $1,206 | 17.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 13 | 13 | $1,040 | $957.73 | 92.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $3,168 | $477.53 | 15.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 12 | 12 | $420.00 | $366.24 | 87.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 27 | 30 | $1,800 | $239.50 | 13.3% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 22 | 25 | $375.00 | $126.26 | 33.7% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 15 | 15 | $300.00 | $91.65 | 30.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 22 | 100 | $500.00 | $8.12 | 1.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 402 | 549 | $102,114 | $28,141 | 27.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 35 | 35 | $5,670 | $3,955 | 69.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 31 | 31 | $8,928 | $1,597 | 17.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 16 | $4,512 | $1,407 | 31.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $4,796 | $1,147 | 23.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 16 | 16 | $1,280 | $1,124 | 87.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 16 | 16 | $470.00 | $426.30 | 90.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 25 | 28 | $1,680 | $206.93 | 12.3% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 18 | 20 | $300.00 | $85.84 | 28.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 18 | 77 | $385.00 | $6.28 | 1.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 212 | 304 | $53,970 | $15,112 | 28.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 48 | 48 | $8,834 | $5,430 | 61.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 49 | 56 | $12,600 | $4,290 | 34.0% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 41 | 41 | $2,460 | $2,340 | 95.1% |
About Jacqueline Small
Jacqueline Small is a Family healthcare provider based in Cumming, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2019. The National Provider Identifier (NPI) number assigned to this provider is 1407415615.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jacqueline Small has received a total of $5,874 in payments from pharmaceutical and medical device companies, with $2,061 received in 2024. These payments were reported across 325 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($5,808).
As a Medicare-enrolled provider, Small has provided services to 2,320 Medicare beneficiaries, totaling 2,922 services with total Medicare billing of $142,575. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Cumming, GA
- Active Since 06/11/2019
- Last Updated 06/11/2019
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1407415615
Products in Payments
- MOUNJARO (Drug) $375.93
- TRELEGY ELLIPTA (Drug) $287.27
- VRAYLAR (Drug) $277.03
- REXULTI (Drug) $234.57
- Wegovy (Drug) $232.87
- XIFAXAN (Drug) $214.20
- Veozah (Drug) $201.86
- NURTEC ODT (Drug) $189.93
- Rybelsus (Drug) $184.13
- UBRELVY (Drug) $164.81
- NEXLETOL (Drug) $153.58
- Ozempic (Drug) $147.24
- EVENITY (Biological) $147.03
- Kerendia (Drug) $136.88
- QULIPTA (Drug) $130.38
- NUZYRA (Drug) $129.11
- BREZTRI (Drug) $128.20
- Auvelity (Drug) $124.74
- EMGALITY (Drug) $108.41
- Otezla (Drug) $105.66
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Cumming
Julia Branch, Nurse Practitioner, NURSE PRACTITIONER
Family — Payments: $38,771
Catherine Lykins, Fnp-C, FNP-C
Family — Payments: $9,950
Kimberly Neadow, Np, NP
Family — Payments: $7,714
Mrs. Danielle Doedens, Msn, Fnp, MSN, FNP
Family — Payments: $5,934
Robin Pingeton, Fnp, FNP
Family — Payments: $5,795
Kanitha Sar, Aprn, Fnp-Bc, APRN, FNP-BC
Family — Payments: $5,741